Is Tobramycin Sulfate Injection in shortage?
Tobramycin Sulfate Injection is listed by FDA as being discontinued by at least one maker (updated Jul 17, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01)
Discontinuation of the manufacture of the drug
Maker contact: 844-646-4398
FDA recalls of Tobramycin Sulfate
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Tobramycin Sulfate Injection:
Tobramycin Sulfate Injection shortage questions
Is Tobramycin Sulfate Injection in shortage?
Tobramycin Sulfate Injection is listed by FDA as being discontinued by at least one maker (updated Jul 17, 2026).
What should I do if I can’t get Tobramycin Sulfate Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.